Diabetes therapy and cancer risk (October 2014)

  • Cleveland Clinic Journal of Medicine
  • December 2014,
  • 81
  • (12)
  • 714;
  • DOI: https://doi.org/10.3949/ccjm.81c.12001
This is a PDF-only article. The first page of the PDF of this article appears above.

Footnotes

  • ↵* Dr. Weiss has disclosed he is on the speakers bureau for multiple pharmaceutical companies, including Takeda, Novo-Nordisk, and Astra Zeneca.

Loading
PDF
Back to top

In this issue

Cleveland Clinic Journal of Medicine

Cleveland Clinic Journal of Medicine

Vol. 81, Issue 12

1 Dec 2014

Table of Contents Table of Contents (PDF) Index by author
  • Print
  • Download PDF
  • Article Alerts

    Alerts for this Article

    Sign In to Email Alerts with your Email Address
  • Email Article

    Email This Article

  • Citation Tools

    Citation Tools

    Diabetes therapy and cancer risk (October 2014)
    • Cleveland Clinic Journal of Medicine
    • December 2014,
    • 81
    • (12)
    • 714;
    • DOI: 10.3949/ccjm.81c.12001

    Citation Manager Formats

  • Share

    Share This Article

    Diabetes therapy and cancer risk (October 2014)
    • Cleveland Clinic Journal of Medicine
    • December 2014,
    • 81
    • (12)
    • 714;
    • DOI: 10.3949/ccjm.81c.12001

Jump to section